Paris
France
4
2019-05-30
4
2020-12-15
These are the the leading inventors for applications assigned to Theravectys:
Theravectys based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Lentiviral vectors for expression of hepatitis B virus (HBV) antigens
#2 | 2017-06-15 ✅ Patent 10,752,668 granted on 2020-08-25Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
#3 | 2016-11-17 ✅ Patent 9,987,351 granted on 2018-06-05Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1
#4 | 2010-11-25 ✅ Patent 8,420,104 granted on 2013-04-16Lentiviral gene transfer vectors and their medicinal applications
Also check out THERAVECTYS's (Paris, France) applicant profile with 4 patent applications submitted.
464181 ⎘